City and County of San Francisco et al v. Purdue Pharma L.P. et al

  1. December 21, 2023

    A Look Back At 2023's Biggest Healthcare Litigation Decisions

    Plenty of healthcare and life science litigation dominated headlines in 2023 — including a couple of opioid decisions that might change how settlements are doled out and how prosecutors charge doctors involved in pill mill schemes.

  2. May 19, 2023

    Walgreens Judge Warns SF $230M Opioid Deal No Candy Jar

    A California federal judge who issued a landmark finding that Walgreens is liable for San Francisco's opioid crisis urged politicians Friday to limit Walgreens' recent $230 million deal exclusively to opioid abatement, saying, "I don't want this to be a pot that everybody dips into based on their political might."

  3. May 17, 2023

    Walgreens To Pay SF $230M After Landmark Opioid Trial Loss

    Walgreens Co. has agreed to pay $230 million to San Francisco for its role in the city's opioid epidemic following a landmark weeks-long bench trial last year that found the pharmacy chain liable for distributing thousands of suspicious painkiller prescriptions in the area without proper screenings, the city announced Wednesday.

  4. November 04, 2022

    SF-Walgreens Opioid Trial Called Off Amid Settlement Talks

    Just days after Walgreens announced its $5 billion tentative settlement of nationwide opioid litigation, a California federal judge called off Monday's remedies trial in connection with an August decision that found the pharmacy giant liable for San Francisco's struggles with rampant opioid abuse.

  5. October 27, 2022

    Walgreens Says It'll Fight SF Estimate 40K Hooked On Opioids

    Walgreens will challenge a California federal judge's estimate that 40,000 San Franciscans suffered from opioid addiction, the retailer told the judge on Thursday ahead of a trial to determine what damages it owes for fueling the crisis, saying the number matters because the city wants it to pay billions for treatment.

  6. October 26, 2022

    SF Details $8B Opioid Plan As Walgreens Remedy Trial Looms

    San Francisco deserves $8 billion from Walgreens to alleviate the opioid epidemic's "calamitous effects," but it expects less money because the company created a problem it "cannot afford to fix," the city said Wednesday ahead of an imminent damages trial.

  7. August 11, 2022

    Calif.'s Broad Nuisance Law Key To Walgreens Opioid Liability

    A California federal judge's decision Wednesday holding Walgreens liable for substantially contributing to the opioid crisis in San Francisco was bolstered by the Golden State's broad public nuisance law, but whether other states similarly apply the legal doctrine remains to be seen, lawyers told Law360.

  8. August 11, 2022

    Winless In Opioid Bouts, Will Pharmacies Throw In The Towel?

    A California federal judge's walloping of Walgreens over its narcotic painkiller sales in San Francisco has left pharmacy chains 0 for 2 in opioid trials and is casting doubt on the companies' apparent plans to continue stepping into the legal ring with government adversaries.

  9. August 10, 2022

    Walgreens Fueled SF Opioid Epidemic, Judge Rules

    Pharmacy giant Walgreens dispensed hundreds of thousands of suspicious prescriptions for narcotic painkillers in San Francisco without proper screening and is liable for ensuing opioid problems in the Bay Area, a California federal judge ruled Wednesday.

  10. August 01, 2022

    Product Liability Cases To Watch: Midyear Review

    More trials are expected to start over claims that drug companies fueled the opioid crisis, and e-cigarette giant Juul is set to face its first case in multidistrict litigation over allegations it misrepresented the safety of its wares. Here is Law360's list of product liability cases to watch for the rest of the year.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!